Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA

Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA

Background/Aim: Treatment of human non-small-cell lung cancer (NSCLC) often involves uses of multiple therapeutic strategies with different mechanisms of action. Here we found that resveratrol (RV) enhanced the anti-tumor effects of epidermal growth factor receptor (EGFR) inhibitor erlotinib in NSCL...

Full description

Bibliographic Details
Main Authors: Peipei Nie, Weicheng Hu, Tao Zhang, Yiju Yang, Benxin Hou, Zhengzhi Zou
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-04-01
Series:Cellular Physiology and Biochemistry
Subjects:
PUMA
Synergistic
Survivin
Erlotinib
Resveratrol
NSCLC
Apoptosis
Online Access:http://www.karger.com/Article/FullText/374030

Internet

http://www.karger.com/Article/FullText/374030

Similar Items